AIxCrypto Holdings, Inc. (AIXC)
AIXC Stock Price Chart
Explore AIxCrypto Holdings, Inc. interactive price chart. Choose custom timeframes to analyze AIXC price movements and trends.
AIXC Company Profile
Discover essential business fundamentals and corporate details for AIxCrypto Holdings, Inc. (AIXC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
23 Jun 2015
Employees
4.00
Website
https://qlgntx.comCEO
Kevin A. Richardson
Description
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
AIXC Financial Timeline
Browse a chronological timeline of AIxCrypto Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
AIXC Stock Performance
Access detailed AIXC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
